Results 111 to 120 of about 10,268 (212)

Lansoprazole of no benefit in children with asthma [PDF]

The Journal of Pediatrics, 2012
openaire   +3 more sources

Evaluating the cost-effectiveness of replacing lansoprazole with vonoprazan for treating erosive oesophagitis. [PDF]

BMJ Open Gastroenterol
Jeyarajan S, K T, Pimpalnerkar S, Deng EZ, Ahmad Z, Banerjee D, de Preux L.   +6 more
europepmc   +1 more source

Effects of lansoprazole suspension on gastric ph in critically-ill, mechanically ventilated patients

, 2000
Kevin Roberts, W. Douglas Pitcher, Byron Cryer   +2 more
openalex   +1 more source

In vitro susceptibility testing of Trichomonas gallinae strains to proton pump inhibitors and nitroimidazoles. [PDF]

Sci Rep
Kerek Á, Csiki BB, Szabó Á, Farkas M, Pitó A, Jerzsele Á, Mag P.   +6 more
europepmc   +1 more source

Lansoprazole induces mucosal protection through gastrin/CCK-B receptor-dependent upregulation of COX-2 in rats

, 2000
Wei‐Hao Sun, Shingo Tsuji, Masahiko Tsujii, Edhi S. Gunawan, Arata Kimura, Yutaka Sasaki, Masatsugu Hori, Sunao Kawano   +7 more
openalex   +1 more source

Long‐term lansoprazole treatment for gastro‐oesophageal reflux disease: clinical efficacy and influence on gastric mucosa [PDF]

, 2001
Karel Geboes, W Dekker, Chris J. Mulder, K. Nusteling   +3 more
openalex   +1 more source

Comparative in vitro assessment of CYP2C19 inhibition by ilaprazole and conventional proton pump inhibitors using a high throughput fluorometric assay. [PDF]

Sci Rep
Priyadharshini A, Vijayakumar TM, Damodharan N, Vasanth KM, Elaiyaraja A.   +4 more
europepmc   +1 more source

A Prospective Trial of Lansoprazole Triple Therapy for Pediatric Helicobacter pylori Infection

, 2000
Harohalli Shashidhar, John Peters, Chuan‐Hao Lin, Rajah Rabah, Ronald Thomas, Vasundhara Tolia   +5 more
openalex   +1 more source

Advances in Gastroesophageal Reflux Disease Management: Exploring the Role of Potassium-Competitive Acid Blockers and Novel Therapies. [PDF]

Pharmaceuticals (Basel)
Hossa K, Małecka-Wojciesko E.
europepmc   +1 more source

Exploring the mechanisms and targets of proton pump inhibitors-induced osteoporosis through network toxicology, molecular docking, and molecular dynamics simulations. [PDF]

Front Pharmacol
Mu Y, Zhou Y, Zhang X, Shao Y.
europepmc   +1 more source